Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pocket ultrasound in GP offices could boost lifesaving aneurysm screening

NCT ID NCT05617326

Diagnosis Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new way to screen for abdominal aortic aneurysm (AAA), a dangerous bulge in the main belly artery that can be fatal if it bursts. Currently, patients must visit a radiologist for an ultrasound, but many don't go. Researchers are training general practitioners (GPs) to use a small, cheap ultrasound device during regular office or home visits. The trial will compare how many people get screened when their GP does it versus the standard referral to a radiologist, aiming to see if this simpler approach increases screening rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultraportable ultrasound screening
What this could lead to
If successful, this could make AAA screening more accessible and convenient, potentially catching dangerous aneurysms earlier and saving lives.
What could go wrong
This is a relatively small, early-stage study (400 participants) focused on screening rates, not long-term health outcomes. GPs may miss aneurysms compared to radiologists, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male * In the absence of a family history of AAA: Patient aged 65 to 75 years, chronic current or past smoker, active smoker (defined as having smoked at least one cigarette per day) or former smoker (defined as having quit smoking less than 20 years ago, regardless of the number of cigarettes smoked). * If there is a family history of AAA: Patient between 50 and 75 years of age * Express consent to participate in the study * Affiliated or beneficiary of a social security plan Exclusion Criteria: * Patient with a legal protection measure * Patient with previous AAA screening less than 5 years old * Patient unable to understand the study / give informed consent (cognitive impairment, communication impairment)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal aortic aneurysm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal aortic aneurysm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cabinet IPSO Brotteaux

    RECRUITING

    Lyon, 69006, France

  • Cabinet IPSO Italie

    RECRUITING

    Paris, 75013, France

  • Cabinet IPSO Nation

    RECRUITING

    Paris, 75011, France

  • Cabinet IPSO Ourcq

    RECRUITING

    Paris, 75019, France

  • Cabinet IPSO Saint Martin

    RECRUITING

    Paris, 75003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.